Drugs used for neurologic and psychiatric conditions increase the risk for bullous pemphigoid : a case-control study
Varpuluoma, Outi; Jokelainen, Jari; Försti, Anna-Kaisa; Turpeinen, Miia; Timonen, Markku; Huilaja, Laura; Tasanen, Kaisa (2019-02-13)
Outi Varpuluoma, Jari Jokelainen, Anna-Kaisa Försti, Miia Turpeinen, Markku Timonen, Laura Huilaja, Kaisa Tasanen, Drugs used for neurologic and psychiatric conditions increase the risk for bullous pemphigoid: A case–control study, Journal of the American Academy of Dermatology, Volume 81, Issue 1, 2019, Pages 250-253, ISSN 0190-9622, https://doi.org/10.1016/j.jaad.2019.02.017
© Elsevier 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/.
https://creativecommons.org/licenses/by-nc-nd/4.0/
https://urn.fi/URN:NBN:fi-fe2019091828594
Tiivistelmä
Abstract
To the Editor: The association between neurologic diseases and bullous pemphigoid (BP) is well established.1 However, it has not yet been established whether drugs that affect the nervous system can influence the onset of BP. The aim of this study was to determine if patients who receive drugs to treat neurologic and psychiatric diseases have an altered risk for BP.
Kokoelmat
- Avoin saatavuus [34264]